Ptc Therapeutics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.1Mgeneral payments (2019-2025)
$211Kresearch payments (2019-2025)
1,207clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $687K
2020 $373K
2021 $422K
2022 $521K
2023 $433K
2024 $372K
2025 $290K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Hematology & Oncology $716K
Surgery $510K
Neurology With Special Qualifications In Child Neurology $485K
Clinical Genetics (M.D.) $354K
Neurology (Psychiatry & Neurology) $169K
Pediatric Rehabilitation Medicine $102K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Robert Spiegel Westfield, NJ Hematology & Oncology $710,463.94
Glenn Steele Danville, PA Surgery $510,228.02
Ashutosh Kumar Hershey, PA Neurodevelopmental Disabilities (Pediatrics) $98,866.30
Craig Mcdonald Sacramento, CA Pediatric Rehabilitation Medicine $87,556.29
Nicola Longo Los Angeles, CA Clinical Genetics (M.D.) $73,247.92
Stanley Nelson Los Angeles, CA Pediatrics $61,537.89
Diana Castro Denton, TX Neurology With Special Qualifications In Child Neurology $58,165.05
Melissa Lah Indianapolis, IN Clinical Molecular Genetics $55,596.06
Timothy Feyma Bloomington, MN Neurology With Special Qualifications In Child Neurology $52,440.76
Michael Kruer Phoenix, AZ Neurodevelopmental Disabilities (Psychiatry & Neurology) $49,172.11

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.